Other languages Indivior PLC

Equities

INDV

GB00BN4HT335

Market Closed - London S.E. Other stock markets 09:05:07 30/04/2024 pm IST			5-day change	1st Jan Change
1,442 ^GBX	-1.44%		-5.13%	+21.69%

25/04	Transcript : Indivior PLC, Q1 2024 Earnings Call, Apr 25, 2024
25/04	London-listed Indivior Confirms Plan for Primary Listing in US	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

London-listed Indivior Confirms Plan for Primary Listing in US	25/04
Indivior Seeks Shareholder Nod for Listing in the United States	25/04
UK-listed drugmaker Indivior seeks shareholder nod for US listing	25/04
Indivior shares down despite profit boost on planned shift to New York	25/04
Indivior Reports Higher Q1 Net Income, Net Revenue	25/04
Indivior plc Reconfirms Earnings Guidance for 2024	25/04
Indivior PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Addex freine ses pertes et se concentre sur sa nouvelle organisation	18/04
Addex dämmt Verluste ein - Fokus auf neue Struktur	18/04
DELFINGEN Industry : Atos, Nexity, Renault...les valeurs à suivre aujourd'hui à Paris	03/04
Addex externalise sa plateforme technologique dans une nouvelle société	03/04
Bilendi : Argan, Delfingen, Solutions 30...les valeurs à suivre demain à Paris -	02/04
Aelis Farma: trésorerie de 20,2 millions, visibilité jusqu'à fin 2025	02/04
C4X Discovery seeks AIM delisting but half-year revenue skyrockets	27/03
Unilever envisage une cotation de sa division glace à Amsterdam	26/03
Indivior PLC Appoints David E. Wheadon, M.D. as Independent Non-Executive Director, Effective from June 1, 2024	21/03
Indivior CCO Richard Simkin sells GBP1 million in shares	18/03
UBS cuts abrdn price target but ups Darktrace's	12/03
Indivior Says Opvee Shows Drug Reverses Opioid-Induced Respiratory Depression Faster Than Naloxone	12/03
Indivior PLC Announces Publication Demonstrating that OPVEE® Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone	12/03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Indivior PLC

Equities

INDV

GB00BN4HT335

Other languages

Filters